Latest News

July 10, 2000
Scientists from the Gladstone Institute of Neurological Disease will present key findings in Alzheimer’s disease research at the World Alzheimer Congress 2000, July 9-18 at the Washington Hilton and Towers in Washington, DC. This first-ever event is bringing together more than 5,000 scientific investigators and health care professionals from all parts of the globe for an international exchange of the latest information in three distinct program areas: pivotal research, bridging research and care, and creative care.
July 10, 2000
Results from two studies proving the efficacy and cost-effectiveness of providing voluntary counseling and testing for HIV-1 in developing countries are reported in the new issue (July 8) of the British medical journal The Lancet.
July 10, 2000
A new study headed by a University of California, San Francisco AIDS researcher has determined that providing the female condom to women who are commercial sex workers in rural South Africa is a highly cost-effective means of preventing HIV transmission...
July 10, 2000
A University of California, San Francisco program that uses certified nurse midwives and nurse practitioners as primary care givers has significantly reduced transmission of HIV from mother to child...
July 08, 2000
A multicenter U.S. study has found that the addition of the immune stimulator interleukin-2 (IL-2) to antiretroviral therapy (ART) appears to improve immunologic function in patients with an intermediate stage of HIV infection and may augment the anti-HIV activity of potent antiretroviral agents. Patients who took IL-2 in addition to their regular therapy had increases in CD4 cell counts—a type of white blood cell that helps fight HIV—and decreases in the amount of virus detectable in their blood.
May 04, 2000
UC San Francisco researchers have discovered a region in the telomerase enzyme that they say could prove to be a target for killing cancer cells and regenerating damaged cells, and could also lead to a possible target for attacking HIV.
March 16, 2000
After a sold out session last fall, the UCSF Mini Medical School returns on April 5 for a spring semester of classes for the general public.  The spring 2000 sessions, entitled “Health Sense from Health Science,” will feature talks on the safety and efficacy of alternative and complementary therapies, the effects of human touch on health and development, and the potentially dangerous interactions of drugs and herbal remedies. (See attached schedule for a complete list of course topics.)
March 14, 2000
In a finding that reveals a link between alcoholism and drug addiction, scientists have discovered that a key step leading to alcohol addiction can be blocked by preventing alcohol from gaining access to nerves in the brain involved in learning.
March 14, 2000
Researchers led by UCSF scientists are reporting that an experimental pain drug known as a kappa-opioid brings pain relief to female rats but not males, a finding that adds weight to a recent UCSF clinical finding, and highlights, they say, the need to evaluate drugs by gender. Traditionally, kappa-opioids have been dismissed as ineffective analgesics in humans, though the drugs have shown mixed results in animal studies, depending on how they have been administered.
March 13, 2000
Bones that refuse to heal may one day be set straight by a drug that stimulates the growth of new blood vessels, according to new research from the University of California, San Francisco.  So far, however, the growth factor drug has been tested only in mice, and it could be years before it is used in hospitals. These results were presented at this week’s annual meeting of the Orthopaedic Research Society, in Orlando, Florida.